NO20084935L - Nikotinbaerende vaksineformulering - Google Patents

Nikotinbaerende vaksineformulering

Info

Publication number
NO20084935L
NO20084935L NO20084935A NO20084935A NO20084935L NO 20084935 L NO20084935 L NO 20084935L NO 20084935 A NO20084935 A NO 20084935A NO 20084935 A NO20084935 A NO 20084935A NO 20084935 L NO20084935 L NO 20084935L
Authority
NO
Norway
Prior art keywords
nicotine
bearing
vaccine formulation
composition formulations
stabilizer
Prior art date
Application number
NO20084935A
Other languages
English (en)
Norwegian (no)
Inventor
Rainer Lang
Gerhard Winter
Lorenz Vogt
Original Assignee
Cytos Biotechnology Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag
Publication of NO20084935L publication Critical patent/NO20084935L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20084935A 2006-05-12 2008-11-24 Nikotinbaerende vaksineformulering NO20084935L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06113895A EP1854478A1 (en) 2006-05-12 2006-05-12 Nicotine-carrier vaccine formulation
PCT/EP2007/054604 WO2007131972A1 (en) 2006-05-12 2007-05-11 Nicotine-carrier vaccine formulation

Publications (1)

Publication Number Publication Date
NO20084935L true NO20084935L (no) 2008-12-15

Family

ID=37882366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084935A NO20084935L (no) 2006-05-12 2008-11-24 Nikotinbaerende vaksineformulering

Country Status (19)

Country Link
US (1) US20090238797A1 (pt)
EP (2) EP1854478A1 (pt)
JP (1) JP2009536936A (pt)
KR (1) KR20090007588A (pt)
CN (1) CN101443038B (pt)
AU (1) AU2007251604B2 (pt)
BR (1) BRPI0711635A2 (pt)
CA (1) CA2650237A1 (pt)
EC (1) ECSP088877A (pt)
IL (1) IL194656A (pt)
MA (1) MA30479B1 (pt)
MX (1) MX2008014398A (pt)
MY (1) MY146654A (pt)
NO (1) NO20084935L (pt)
NZ (1) NZ596572A (pt)
RU (1) RU2465007C2 (pt)
TN (1) TNSN08453A1 (pt)
WO (1) WO2007131972A1 (pt)
ZA (1) ZA200808489B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2007070682A2 (en) 2005-12-15 2007-06-21 Massachusetts Institute Of Technology System for screening particles
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
JP2010523595A (ja) 2007-04-04 2010-07-15 マサチューセッツ インスティテュート オブ テクノロジー ポリ（アミノ酸）ターゲッティング部分
EP1982729A1 (en) * 2007-04-20 2008-10-22 Cytos Biotechnology AG Vaccination Regimen for B-Cell Vaccines
JP2011500569A (ja) 2007-10-12 2011-01-06 マサチューセッツ インスティテュート オブ テクノロジー ワクチンナノテクノロジー
US8343497B2 (en) * 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en) * 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
PL213166B1 (pl) * 2008-10-29 2013-01-31 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów
AR076284A1 (es) 2009-04-29 2011-06-01 Bayer Schering Pharma Ag Inmunoconjugados de antimesotelina y usos de los mismos
EA201390660A1 (ru) 2010-11-05 2013-11-29 Селекта Байосайенсиз, Инк. Модифицированные никотиновые соединения и связанные способы
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
EP2646051A4 (en) 2010-12-02 2014-05-28 Oncolytics Biotech Inc FORMULATIONS OF LIQUID VIRUSES
MX2015008944A (es) * 2013-01-15 2016-06-21 Teva Pharma Proceso de liofilizacion.
WO2015059147A1 (en) * 2013-10-25 2015-04-30 Bayer Pharma Aktiengesellschaft A novel stable formulation
EP4026568A1 (en) 2015-04-17 2022-07-13 CureVac Real Estate GmbH Lyophilization of rna
EP3297682B1 (en) 2015-05-20 2021-07-14 CureVac AG Dry powder composition comprising long-chain rna
WO2016184575A1 (en) 2015-05-20 2016-11-24 Curevac Ag Dry powder composition comprising long-chain rna
WO2017047089A1 (en) * 2015-09-16 2017-03-23 Shin Nippon Biomedical Laboratories, Ltd. Vaccine compositions
US11166915B2 (en) 2016-09-16 2021-11-09 Leukocare Ag Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
US11510871B2 (en) 2016-09-16 2022-11-29 Leukocare Ag Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
CN112512480B (zh) * 2018-05-21 2024-10-01 中外制药株式会社 被封入玻璃容器的冷冻干燥制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1329760C (en) * 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media
JPH05331071A (ja) * 1992-01-17 1993-12-14 Asahi Chem Ind Co Ltd カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法
US6288030B1 (en) * 1993-12-22 2001-09-11 Amgen Inc. Stem cell factor formulations and methods
ATE362380T1 (de) * 1995-03-31 2007-06-15 Xenova Res Ltd Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie
US6232082B1 (en) * 1998-12-01 2001-05-15 Nabi Hapten-carrier conjugates for treating and preventing nicotine addiction
AU7658101A (en) * 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
CA2487849A1 (en) * 2002-07-18 2004-01-29 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof

Also Published As

Publication number Publication date
EP1854478A1 (en) 2007-11-14
CA2650237A1 (en) 2007-11-22
MA30479B1 (fr) 2009-06-01
JP2009536936A (ja) 2009-10-22
EP2021024A1 (en) 2009-02-11
MY146654A (en) 2012-09-14
ZA200808489B (en) 2009-10-28
IL194656A0 (en) 2011-08-01
NZ596572A (en) 2013-04-26
AU2007251604A1 (en) 2007-11-22
IL194656A (en) 2011-12-29
US20090238797A1 (en) 2009-09-24
CN101443038B (zh) 2012-07-04
BRPI0711635A2 (pt) 2011-11-08
KR20090007588A (ko) 2009-01-19
RU2008148830A (ru) 2010-06-20
MX2008014398A (es) 2009-02-06
TNSN08453A1 (en) 2010-04-14
RU2465007C2 (ru) 2012-10-27
WO2007131972A1 (en) 2007-11-22
ECSP088877A (es) 2008-12-30
CN101443038A (zh) 2009-05-27
AU2007251604B2 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
NO20084935L (no) Nikotinbaerende vaksineformulering
NO20090175L (no) Stabile laquinimod sammensetninger
ATE464902T1 (de) Stabile pharmazeutische zubereitungen von montelukast-natrium
NO20075136L (no) Nye liposompreparater
MY167123A (en) Conveniently implantable sustained release drug compositions
AR060187A1 (es) Composicion inmunogenica
BRPI0710508B8 (pt) composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído
DK1940243T3 (da) Kostfiberformulering og fremgangsmåde til indgivelse
ECSP088239A (es) Composición de liberación de fármaco sostenida
BRPI0717498A2 (pt) Composições, métodos de preparo de uma solução para preparo cirúrgico utilizada para desinfetar uma região pré-operatória, métodos de desinfecção, e dispositivo médico.
UY30789A1 (es) Derivados de adenina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
BR112015023391A8 (pt) formulações de conjugados anticorpo-droga anti-egfr
UY30460A1 (es) Compuestos terapéuticos
NO20082269L (no) Nye piperaziner som antimalariamidler
EP4582105A3 (en) Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
BR112014005134A2 (pt) composição farmacêutica de dissolução rápida
NO20092998L (no) Flytende formuleringer, som danner dermal film, for frigjoring av legemidler til huden
ECSP088240A (es) Composición de trazodona para administración una vez por día
NO20061245L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en bisfosfon
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
AR057946A1 (es) Formulacion de zonisamida de liberacion sostenidda
BR112015022385A2 (pt) droga para uma doença respiratória
WO2009032843A3 (en) Deuterated ethambutols and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application